Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             223 results found
no title author magazine year volume issue page(s) type
1 A case of delayed onset immune-related optic neuritis after combined immunotherapy treatment for metastatic melanoma Beselaar, Z.
2 S1 p.
 article
2 Adjuvant lymph node radiotherapy and immunotherapy in stage III melanoma Marxgut, L.
2 S1 p.
 article
3 Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan Namikawa, K.
2 S1 p.
 article
4 Adverse Effects in Elderly Patients (≥ 85 years old) with Advanced Basal Cell Carcinoma Treated with Sonidegib: A multicenter retrospective study Martos-Cabrera, L.
2 S1 p.
 article
5 Age over 90 years is an unfavorable prognostic factor for resectable cutaneous squamous cell carcinoma Saito-Sasaki, N.
2 S1 p.
 article
6 ALDH1A3-acetaldehyde potentiates melanoma heterogeneity Patton, E.E.
2 S1 p.
 article
7 All-trans retinoic acid activity in Merkel cell carcinoma cells: implication of the retinoid pathway Mazziotta, C.
2 S1 p.
 article
8 AMBRA1 is a predictive biomarker of melanoma response to targeted therapy Di Leo, L.
2 S1 p.
 article
9 A Multicenter Prospective Study of Electronic Skin Surface Brachytherapy for Keratinocyte Carcinoma: Long-term Follow Up and Correlation with Reflectance Confocal Microscopy Barker, C.
2 S1 p.
 article
10 ANALYSIS OF GLOBAL Skin-Cancer Epidemiology and Correlation with Dermatologist Density and Population Risk Factors Salah, S.
2 S1 p.
 article
11 Analysis of risk factors in melanoma survivors for the development of non-melanoma skin cancer Luque-Luna, M.
2 S1 p.
 article
12 Analysis of the long-term survival of patients with thin melanomas using comprehensive, population-based Australian data Varey, A.H.
2 S1 p.
 article
13 Anhidrotic ectodermal dysplasia with multiple cutaneous squamous cell carcinomas in sun-exposed areas Isei, T.
2 S1 p.
 article
14 A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma Kaczmar, J.
2 S1 p.
 article
15 A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastatic or unresectable melanoma (RELATIVITY-127) Long, G.V.
2 S1 p.
 article
16 A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients With Resectable Cutaneous Squamous Cell Carcinoma Schadendorf, D.
2 S1 p.
 article
17 A retrospective multicenter study on the real-world efficacy of chemotherapy in 204 Japanese patients with advanced extra-mammary Paget's disease Miyashita, A.
2 S1 p.
 article
18 Assessment of facial pigmented lesions using Line-field Confocal Optical Coherence Tomography and its correlation with Reflectance Confocal Microscopy and histopathology Lenoir, C.
2 S1 p.
 article
19 Assessment of performance in clinical risk prediction tools for cutaneous melanoma in the UK population Manton, R.
2 S1 p.
 article
20 Assessment of the impact of a dermoscopy training associated with an artificial intelligence on general practitioner residents Dorado Cortez, C.
2 S1 p.
 article
21 A successful treatment of locally advanced squamous cell carcinoma with cemiplimab in a patient with multiple myeloma Ferreira, M.C.C.
2 S1 p.
 article
22 A systematic review of changes in melanocytic naevi during immune checkpoint inhibition and targeted therapy Bruijn, T.V.M.
2 S1 p.
 article
23 Atypical granular cell tumor - a case for worry? Long, S.V.
2 S1 p.
 article
24 Atypical spitzoid lesions: A molecular and histological analysis of two NTRK driven cases Teufer, M.
2 S1 p.
 article
25 Augmented intelligence using 2D and 3D total body photography for melanoma screening: Patient and dermatologist perspectives in real-world application Goessinger, E.
2 S1 p.
 article
26 Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients” Ortiz Brugués, A.
2 S1 p.
 article
27 Benefit of immunotherapy for advanced melanoma in two patients with xeroderma pigmentosum Rivas Segovia, A.C.
2 S1 p.
 article
28 Beyond tropical verrucose syndrome: new associations of skin cancer and verrucous lesions Peñaranda, E.
2 S1 p.
 article
29 BRCA1-associated-protein 1 tumour predisposition syndrome (BAP1-TPDS) presenting with multiple BAP1-inactivated melanocytic tumours – a rare hereditary tumour syndrome Loh, C.H.
2 S1 p.
 article
30 Breslow thickness depends significantly on the individual suspecting melanoma: the importance of guaranteeing access to a dermatologist López-Pardo Rico, M.
2 S1 p.
 article
31 Cancers of the skin and mucous membranes in people living with HIV compared to the general population Ciccarese, G.
2 S1 p.
 article
32 Cell cannibalism: a possible source of therapy resistant melanoma-fibroblast hybrids German, P.
2 S1 p.
 article
33 Cellular Origin of Basal Cell Carcinoma via Reflectance Confocal Microscopy Ambrosio, L.
2 S1 p.
 article
34 Cemiplimab Immunotherapy in the Treatment of Cutaneous Squamous Cell Carcinoma Kozéki, Z.
2 S1 p.
 article
35 Cemiplimab in the treatment of locally advanced cutaneous squamous cell carcinoma: a case series study Pradeau, M.A.
2 S1 p.
 article
36 Changes in the pigmentation of melanocytic nevi associated with the use of self-tanners: a diagnostic challenge in patients at risk of melanoma Camiña-Conforto, G.
2 S1 p.
 article
37 Characterization of 10 cutaneous tumors with ex vivo LC-OCT: A novel tool in dermato-oncological surgery with margin control? Rosés Gibert, P.
2 S1 p.
 article
38 Circulating tumor DNA: a promising biomarker in stage III BRAF+ melanoma Roccuzzo, G.
2 S1 p.
 article
39 Clinical and dermatoscopic features of multiple piloleiomyomas - a case report Słomiak-Wąsik, A.
2 S1 p.
 article
40 Clinical characteristics and surgical approach of patient with SAMPUS/ Melanoma and pleomorphic dermal sarcoma on face Petrovic Popovic, D.
2 S1 p.
 article
41 Clinical features and treatment patterns of patients with classic Kaposi sarcoma in Greece Kokkali, S.
2 S1 p.
 article
42 Clinical response to immune checkpoint inhibitors in immunocompromised patient with metastatic non-melanoma skin cancer Morales, P. Díaz
2 S1 p.
 article
43 Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma Ahmed, Y.
2 S1 p.
 article
44 Comparison of the efficacy of skin examination using 3D total body photography to clinical and dermoscopic examination Gellrich, F.F.
2 S1 p.
 article
45 Complete regression of Bowen's disease after incisional biopsy: case report Cespede, M.
2 S1 p.
 article
46 Complete remission of malignant lung metastasis of melanoma with stereotacticradiotherapy (Case report) Danyi, T.
2 S1 p.
 article
47 Complete response as prognostic marker of prolonged survival in metastatic melanoma Bafaloukos, D.
2 S1 p.
 article
48 Cost -effectiveness of Surgical Excision versus Photodynamic Therapy and 5-Fluorouracil Cream in Treatment of Bowen’s Disease: a trial based economic evaluation Ahmady, S.
2 S1 p.
 article
49 Cost-of-illness of skin cancer: A systematic review Meertens, A.
2 S1 p.
 article
50 Cumulative sum analysis-integrated e-learning for differentiation between basal cell carcinoma and non-basal cell carcinoma on optical coherence tomography: a diagnostic cohort study Wolswijk, T.
2 S1 p.
 article
51 Delphi Consensus of Tumor Stage Based Treatment Approach to High-Risk Cutaneous Squamous Cell Carcinoma Patel, V.
2 S1 p.
 article
52 Dermatological adverse events due to oncotherapy: the necessity for a new classification Pagani, A.
2 S1 p.
 article
53 Dermoscopic, Reflectance Confocal Microscopy and Line-field Optical Coherence Tomography features of Cutaneous Lymphomas D'onghia, M.
2 S1 p.
 article
54 Dermoscopy of basal cell carcinoma explained by line-field confocal optical coherence tomography: preliminary results of a correlation study Azahaf, A.
2 S1 p.
 article
55 Desmoplasia, a risk factor for recurrence and metastasis in cutaneous squamous cell carcinoma: an interobserver agreement study among dermatopathologists Crüts, E.
2 S1 p.
 article
56 Developing a patient-informed conceptual model of advanced and metastatic melanoma McFadden, S.
2 S1 p.
 article
57 Diagnosis of vulvar pigmented lesions with confocal microscopy Valenti, M.
2 S1 p.
 article
58 Diagnostic criteria for melanocytic lesions in LC-OCT Pérez-Anker, M.J.
2 S1 p.
 article
59 Discoidin domain receptor 1, a melanoma immunomodulator Lutz, C.
2 S1 p.
 article
60 Does the interval between melanoma diagnosis and surgery have an impact on outcomes? A systematic review and meta-analysis Strazda, A.E.
2 S1 p.
 article
61 Dupilumab for the treatment of bullous pemphigoid triggered by melanoma immunotherapy Tsentemeidou, A.
2 S1 p.
 article
62 Early detection of skin cancer: a nurse-initiated consultation to improve dermatology access Shen, A.
2 S1 p.
 article
63 Early recurrence in a pooled international cohort of melanoma patients treated with adjuvant nivolumab in a real-world setting Mortier, L.
2 S1 p.
 article
64 Effects of temozolomide on tumor mutation burden and microsatellite instability in melanoma cells Sawada, M.
2 S1 p.
 article
65 Efficacy and safety of tirbanibulin 1% ointment for the treatment of actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study) Gilaberte, Y.
2 S1 p.
 article
66 Elevating MAPK Pathway Suppression with Combinatorial ERK Inhibitors Kosnopfel, C.
2 S1 p.
 article
67 Enhancement of sun-damaged skin qualities with tirbanibulin (SunDamage Study) Kopera, D.
2 S1 p.
 article
68 Epidemiological indicators of melanoma in the Republic of Uzbekistan Ibragimova, D.
2 S1 p.
 article
69 Estimating Occupational Exposure to Ultraviolet Radiation Using the Canadian Occupation Exposure Matrix (CANJEM) in a Nationwide Cohort of French Adults Amari, B.
2 S1 p.
 article
70 Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients Jambusaria-Pahlajani, A.
2 S1 p.
 article
71 Evaluation of anticancer therapy- related dermatologic adverse events: insights from fda's faers dataset Salah, S.
2 S1 p.
 article
72 Evaluation of efficacy and tolerability of a repairing protective cream containing the postbiotic Aquaphilus Dolomiae extract G2 for onco-dermatological indications Stennevin, A.
2 S1 p.
 article
73 Examining the Association Between Ruxolitinib and Aggressive Cutaneous Squamous Cell Carcinoma: Is There a Justified Need for Screening Programs? Gruber-Velasco, F.
2 S1 p.
 article
74 Exceptional response to rechallenge of BRAF/MEK inhibitors in patients with primary acquired resistance to targeted therapy Ziółkowska, B.
2 S1 p.
 article
75 Exploring “Decision regret” in Adjuvant-Treated Melanoma Patients– results from a cross-sectional survey on 200 participants Grünke, T.
2 S1 p.
 article
76 Factors Influencing the Risk of Involved and Close Squamous Cell Carcinoma Excision and Recurrence: A Comprehensive Analysis over a 7-Year Period Patel, M.K.
2 S1 p.
 article
77 First description of atypical fibroxanthoma in Line-Field Confocal Optical Coherence Tomography and comparison with Reflectance Confocal Microscopy Lenoir, C.
2 S1 p.
 article
78 First-line Nivolumab plus Ipilimumab in patients with advanced melanoma previously treated with adjuvant systemic therapy Kisielewska, K.
2 S1 p.
 article
79 Flow cytometry-based strategy to characterize the microenvironment of skin tumors as a tool for preclinical research Reyes-Garau, D.
2 S1 p.
 article
80 Four years experience in Mohs Surgery Greco, A.G.
2 S1 p.
 article
81 Gamification of Dermoscopy Education Using a Smartphone Mobile Platform: A Pilot Study Aponso, S.
2 S1 p.
 article
82 Gastric Melanoma: Primary or Secondary Forms? 2 case reports Hanis, C.
2 S1 p.
 article
83 Gene Signatures predict immune-related skin adverse events in melanoma patients Mallardo, D.
2 S1 p.
 article
84 Genetic sequencing and Novel Therapeutic Targets in Perianal Extramammary Paget Disease Lavin, L.
2 S1 p.
 article
85 High dose Vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of randomized a double-blind, placebo-controlled study (ViDMe trial) De Smedt, J.
2 S1 p.
 article
86 Higher intraoperative detection rate of suspicious non-palpable lesions using wire marking in skin cancer patients Tietze, J.K.
2 S1 p.
 article
87 Histopathologic Correlation of Structures Seen in Super High Magnification Dermoscopy of Basal Cell Carcinoma Pogorzelska-Dyrbuś, J.
2 S1 p.
 article
88 HPV vaccination practices among organ transplant recipients in France de Quatrebarbes, J.
2 S1 p.
 article
89 Hypertrophic Lichen Planus associated with Pembrolizumab Sato-Sano, M.
2 S1 p.
 article
90 Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis Amaral, T.
2 S1 p.
 article
91 Identification of two transcriptomic subgroups in actinic keratosis: differentiation between normal skin and cutaneous squamous cell carcinoma-like profiles using RNA-seq Corchete-Sánchez, L.
2 S1 p.
 article
92 IL-17 mediates angiogenesis in Basal Cell Carcinomas and Squamous Cell Carcinomas Cunha, D.
2 S1 p.
 article
93 Imaging in Locally Advanced and Metastatic Basal Cell Carcinoma: Findings and Recommendations Zwanenburg, A.
2 S1 p.
 article
94 Immune-related adverse events with adjuvant anti-PD-1 therapy in high-risk resected melanoma: a single-center experience Csányi, I.
2 S1 p.
 article
95 Immunohistochemical analysis of AMBRA1 and loricrin expression reveals maintained expression in the epidermis overlying a range of benign melanocytic naevi but which may be altered in some melanoma in situ cases Husain, A.
2 S1 p.
 article
96 Immunotherapy after progression to immunotherapy: Pembrolizumab and Lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition Lyrarakis, G.
2 S1 p.
 article
97 Impact of Immune-Related Adverse Events on Melanoma Outcomes: A Comprehensive Analysis Ahmed, Y.
2 S1 p.
 article
98 Incidence and surgical treatment trends of non-melanoma skin cancer in Denmark 2002-2021 Holdam, A.S.K.
2 S1 p.
 article
99 Incidence, local recurrence, metastasis, disease-specific survival, and overall survival in patients with cutaneous rhabdomyosarcoma: A nationwide cohort study of 24 patients Dueled, S.H.
2 S1 p.
 article
100 Incidence Of Skin Melanoma And Mortality From It Among The Population Of The Republic Of Belarus (epidemiological data from a 30-year study) Prakoshyn, A.
2 S1 p.
 article
101 Insights on different erythroderma features in Sezary syndrome: a prospective validation study Roccuzzo, G.
2 S1 p.
 article
102 Integrated transcriptomics reveals cellular and molecular interactions in pruritic cutaneous T-cell lymphoma Roggo, A.
2 S1 p.
 article
103 Integrating a Clinicopathological Risk Prediction Model into the European Guideline for Cutaneous Squamous Cell Carcinoma Steijlen, O.
2 S1 p.
 article
104 Interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: Time to onset of adverse events Gutzmer, R.
2 S1 p.
 article
105 InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma Weber, J.S.
2 S1 p.
 article
106 Ipilimumab and nivolumab in uveal melanoma: report on toxicity and treatment intensity Ciernik, A.
2 S1 p.
 article
107 Is melanoma a death sentence in Black Africans? A three-year institutional study from a resource limited setting Adoke, K.
2 S1 p.
 article
108 Is There a Distinctive Molecular Identity for Sinonasal Malignant Mucosal Melanoma Compared to Cutaneous Melanoma? Molina-García, M.
2 S1 p.
 article
109 Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1 Reger de Moura, C.
2 S1 p.
 article
110 Kissing lesions on penis – a very rare case report Buljan, M.
2 S1 p.
 article
111 Leg lymphoma not leg type lymphoma Mercader Salvans, J.
2 S1 p.
 article
112 Level of satisfaction with treatment and clinical care at the Skin Cancer Unit in patients with cutaneous melanoma - A single specialist referral centre analysis Ziętek, M.
2 S1 p.
 article
113 Localized multiple spiradenomas are caused by somatic mosaicism in ALPK1 hotspot mutation Hirano-Lotman, Y.
2 S1 p.
 article
114 Long-term survival of melanoma patients according to primary tumour thickness – an Australian population-based study Varey, A.H.
2 S1 p.
 article
115 Loss of AMBRA1 expression in the tumour endothelium as a potential biomarker to identify AJCC stage I/II melanomas at high risk of metastasis Lovat, P.
2 S1 p.
 article
116 Lymph Node Operative Experience in the UK – What’s Changed? Jones, O.
2 S1 p.
 article
117 Macrophages: A Key Population for the Resistance Acquisition in BRAF Mutant Melanoma Sisó Camarasa, P.
2 S1 p.
 article
118 Malignant transformation during anti-TNF treatment of Hidradenitis suppurativa Rudzikaite-Fergize, G.
2 S1 p.
 article
119 Management and outcomes following the first cutaneous squamous cell carcinoma in kidney transplant recipients: the United Kingdom COAST (Contemporary Outcomes After cutaneous SCC in Transplant recipients) study Peleva, E.
2 S1 p.
 article
120 Management of muscle spasms induced by sonidegib in a 93-year-old patient with a multimodal gait disorder Helf, C.
2 S1 p.
 article
121 Measuring health-related quality of life in patients with keratinocyte carcinoma: A multicenter cross-sectional study Meertens, A.
2 S1 p.
 article
122 Melanoma Diagnostic Accuracy in a Total Body Photography System with an AI Dermoscopy App Drugge, R.
2 S1 p.
 article
123 Melanoma in Children, Adolescents, and Young Adults: The Spanish Cohort of the MELCAYA Consortium Patricio da Silva-Junior, R.M.
2 S1 p.
 article
124 Melanoma Prognosis and Associated Risk Factors: A Retrospective Cohort Study Using Semantic Map Analysis Zahn, C.A.
2 S1 p.
 article
125 Merkel cell carcinoma cells proliferation is inhibited by the DNA methyltransferases inhibitor guadecitabine via methylome modulation Rotondo, J.C.
2 S1 p.
 article
126 miR-146a-5p and miR-21-5p as Potential Biomarkers of Malignant Melanoma Venturi, F.
2 S1 p.
 article
127 Multimodal skin imaging of a dermatofibrosarcoma protuberans using line-field confocal optical coherence tomography, ultra-high frequency ultrasound and reflectance confocal microscopy Boussingault, L.
2 S1 p.
 article
128 Nationwide study of the treatment options of lentigo maligna and recurrence rates in the Netherlands Zoutendijk, J.
2 S1 p.
 article
129 Neoadjuvant Vismodegib plus Mohs surgery for locally advanced periocular basal cell carcinoma. Real world scenario Gonzalez, A.
2 S1 p.
 article
130 Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting Ciobotariu, I.
2 S1 p.
 article
131 New designed, non-invasive diagnostic tools for the diagnosis of oral mucosal lesions Ardigo, M.
2 S1 p.
 article
132 New differential diagnosis of melanoma. ¿Induced? Peñaranda Contreras, E.O.
2 S1 p.
 article
133 New digital imaging technique for the follow-up of locally advanced basal cell carcinoma treated with systemic therapy Di Stefani, A.
2 S1 p.
 article
134 Next generation sequencing (NGS) in melanoma patients: a descriptive study of a Canarian cohort with suspected cutaneous melanoma-dominant syndrome Castro Gonzalez, E.N.
2 S1 p.
 article
135 Novel, non-invasive method for classification of melanocytic lesions using a direct illumination multispectral imaging camera Goessinger, E.
2 S1 p.
 article
136 “One spot check”; a new strategy to increase dermatology access for worrisome skin lesions Kips, J.
2 S1 p.
 article
137 Optimizing Healing: Evaluating Ozone Therapy's Impact on Skin Cancer Surgery Reconstruction at the Amazon Head and Neck Surgery Center Feltrim, E.
2 S1 p.
 article
138 Paediatric Spitzoid Neoplasms: a 10-year retrospective study Herzum, A.
2 S1 p.
 article
139 Patient and physician-reported outcomes with tirbanibulin 1% ointment for actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study) Gilaberte, Y.
2 S1 p.
 article
140 Patient-orientated evaluation of treatment of non-melanoma skin cancer with Rhenium-188 compared to surgery Tietze, J.K.
2 S1 p.
 article
141 Patient reported outcomes in the multidisciplinary treatment of patients with high-risk cutaneous squamous cell carcinoma in the head-neck area Crüts, E.
2 S1 p.
 article
142 Patients who forego sentinel lymph node biopsy after 31-GEP testing are not harmed: A prospective, multicenter analysis Guenther, J.M.
2 S1 p.
 article
143 Patient treatment preferences in unresectable/metastatic BRAF-mutated melanoma: a qualitative study Amaral, T.
2 S1 p.
 article
144 Patient with metatypical metastatic Basal Cell Carcinoma treated with Vismodegib Amarillo, D.
2 S1 p.
 article
145 PBX1 deregulation promotes melanoma progression and metastasis through alternative splicing Sui, Y.
2 S1 p.
 article
146 Pembrolizumab treatment for advanced pleomorphic dermal sarcoma, a three-case series in a spanish tertiary-level hospital Cheuque, R.P. Román
2 S1 p.
 article
147 Performance of a new classification system based on the eight most relevant prognostic factors for cutaneous squamous cell carcinoma: a retrospective cohort study showing limits to risk stratification with clinical and histopathological risk factors Cardona-Machado, C.
2 S1 p.
 article
148 Perineural invasion for risk stratification in cutaneous squamous cell carcinoma: a scoping review Moermans, M.
2 S1 p.
 article
149 Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetinib (TACo) in patients (pts) with PD1 refractory metastatic brain metastases (MBM) Burton, E.
2 S1 p.
 article
150 Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress Bhatia, S.
2 S1 p.
 article
151 Phenocopies in melanoma families with germline mutations in CDKN2A are associated to MC1R polymorphisms and high total body nevus count Luna, A.
2 S1 p.
 article
152 Porokeratosis Ptychotropica: The risk of cancerization and treatment options Loh, C.H.
2 S1 p.
 article
153 Predicting sentinel node positivity in patients with primary cutaneous melanoma: an international multicentre study validating and refining the MIA risk calculator Varey, A.H.
2 S1 p.
 article
154 Prediction of melanoma metastasis using dermatoscopy deep features. An international multicenter cohort study Lallas, K.
2 S1 p.
 article
155 Predictors of recurrence and progression in poorly differentiated cutaneous squamous cell carcinomas: insights from a real-life experience Roccuzzo, G.
2 S1 p.
 article
156 Pregnancy-associated melanoma- a pilot study Buljan, M.
2 S1 p.
 article
157 Pre-treatment with topical tirbanibulin of surrounding Non Melanoma Skin Cancer cancerization field to improve surgical outcome Gualdi, G.
2 S1 p.
 article
158 Primary radiotherapy in older adults with basal cell carcinoma: results of the prospective, multicenter BATOA cohort study on treatment burden, short-term outcomes and a comparison with surgically treated patients Mangnus, J.E.
2 S1 p.
 article
159 Prognostic factors for treatment failure of photodynamic therapy and5-fluorouracil in Bowen’s disease Ahmady, S.
2 S1 p.
 article
160 Prognostic impact of the surgical deep margin distance of invasive acral melanoma of the sole: A multi-institutional retrospective study Koizumi, S.
2 S1 p.
 article
161 Prognostic significance of sentinel node tumor burden in Merkel Cell Carcinoma Zijlker, L.
2 S1 p.
 article
162 Prognostic value of tumor microenvironment molecules in the response to immunotherapy in advanced melanoma Parra-Navarro, L.
2 S1 p.
 article
163 Prospective multicenter comparative study of dermoscopic images of a standard dermatoscope and an Autonomous TBP/Dermoscopic Imaging device (DeviskanR) ("Deviskan QS"-Quality Study) Malvehy, J.
2 S1 p.
 article
164 Proteomic Profiling of Cutaneous Squamous Cell Carcinoma Samples from Solid Organ Transplant Recipients and Immunocompetent Patients Azimi, A.
2 S1 p.
 article
165 Psychological distress and need for psycho-oncological support in high-risk patients for melanoma and melanoma survivors: Patient-reported outcomes of a prospective study Mueller, A.M.
2 S1 p.
 article
166 Quality-of-Life Assessment in Spanish Stage III Immunotherapy Patients: A Prospective Observational Study Crespí-Payeras, F.
2 S1 p.
 article
167 Radioimmunotherapy Sequence Impact on Clinical Outcomes of Patients with Melanoma Brain Metastases: A Meta-analysis of Comparative Studies Haddad, P.
2 S1 p.
 article
168 Real-World Evaluation of ImmuCare Patient-Reported Outcomes in Melanoma Patients Treated with Immune-Checkpoint Inhibitors Belkaïd, S.
2 S1 p.
 article
169 Real-world outcomes for advanced melanoma in the adjuvant and unresectable setting: Single-center registry analysis Staeger, R.
2 S1 p.
 article
170 Real-world outcomes of adjuvant therapy in melanoma: an Italian referral center experience Roccuzzo, G.
2 S1 p.
 article
171 Redefine Individual Melanoma Patient Stratification with Artificial Intelligence and Computational Analysis Ficapal, J.
2 S1 p.
 article
172 RESCUE STUDY – International Survey on training of Dermatology Residents in Supportive Oncodermatology Ortiz Brugués, A.
2 S1 p.
 article
173 Right-Sided Lateralisation of Basal Cell Carcinoma and Squamous Cell Carcinoma in a UK Cohort Tao, C.
2 S1 p.
 article
174 Risk factors on developing brain metastasis from melanoma: A sistematic review Freitas, M.
2 S1 p.
 article
175 RNA helicase DHX9 enables PBX1 mRNA translation by unfolding RNA G-quadruplex in melanoma Sui, Y.
2 S1 p.
 article
176 Role of eIF6 in Modulating Response to BRAF Inhibitors and Acquired Resistance in Cutaneous Melanoma Kyriakopoulos, G.
2 S1 p.
 article
177 Role of the COVID-19 pandemic on the incidence and stage at initial diagnosis of cutaneous melanoma: a retrospective national study from the French Clinical Database of Melanoma Patients (RIC-Mel) Skowron, F.
2 S1 p.
 article
178 Sarcopenia as a prognostic indicator in advanced melanoma; a retrospective cohort study McCrossan, S.
2 S1 p.
 article
179 Sex differences and its impact on treatment outcomes of advanced melanoma in Germany – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG Leven, A.-S.
2 S1 p.
 article
180 Single-cell and spatial transcriptomic analysis of primary (nevus-associated)-melanoma van de Haar, L.
2 S1 p.
 article
181 Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets Louveau, B.
2 S1 p.
 article
182 Skin and Ultraviolet Neoplasia Transplant Risk Assessment Calculator (SUNTRAC): Perspectives from the EUSCAP database in a cohort of kidney transplant recipients Al Bouzidi, W.
2 S1 p.
 article
183 Slow Mohs Micrographic Surgery: A Service Evaluation Reid, N.
2 S1 p.
 article
184 Slow Mohs Micrographic Surgery in the management of Extramammary Paget’s Disease Reid, N.
2 S1 p.
 article
185 Squamoid Eccrine Ductal Carcinoma: A Case Series of Three Patients Tudurachi, I.
2 S1 p.
 article
186 Staging of Mucosal Melanoma of the Head and Neck Jeong, Y.J.
2 S1 p.
 article
187 Stratified processing of skin lesions through deep learning Clauwaert, V.
2 S1 p.
 article
188 Sun awareness and prevention in chemotherapy patients: a comparative study Stennevin, A.
2 S1 p.
 article
189 Sun Protection Patterns Among Organ Transplant Recipients and Non-Organ Transplant Patients with Skin Cancers Oh, C.C.
2 S1 p.
 article
190 Surgical treatment of external ear skin melanoma: literature review and one-center experience Kukushkina, M.
2 S1 p.
 article
191 Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy Yung, A.E.
2 S1 p.
 article
192 Targeting autophagy as a therapeutic intervention in BRAFV600E melanoma cells through ULK-1 inhibition Ríos Martínez, C.
2 S1 p.
 article
193 Tebentafusp effect on the tumoural landscape in metastatic uveal melanoma – a post-mortem study Beland, C.
2 S1 p.
 article
194 The clinical utility of comprehensive genomic profiling tests for patients with advanced malignant melanoma in a real-world setting: A retrospective analysis from a single cancer center Matsui, Y.
2 S1 p.
 article
195 The Correlation Between Clinical and Pathological Tumor Size in Cutaneous Squamous Cell Carcinoma and the Risk of Erroneous Downstaging Ceran, M.
2 S1 p.
 article
196 The Dutch Early-Stage Melanoma Study (D-ESMEL): a Discovery Set and Validation Cohort to Predict the Absolute Risk of Distant Metastases in Stage I/II Cutaneous Melanoma Zhou, C.
2 S1 p.
 article
197 The Dutch Keratinocyte Cancer Collaborative: real-world linked health care data to identify and follow-up patients with advanced cutaneous squamous carcinoma on a nationwide level Eggermont, C.
2 S1 p.
 article
198 The health economic impact of the 31-gene expression profile test for treatment and surveillance management plans in patients with cutaneous melanoma Zakria, D.
2 S1 p.
 article
199 The interest of dermascopy X400 technique interpreted by non dermatologists and an artificial intelligence software in the identification of pigmented genital lesions Bruet, M.
2 S1 p.
 article
200 The practice of using Vacuum-Assisted Closure in combination with free skin grafts in the treatment of wound defects after removal of malignant skin neoplasms Ostafiichuk, V.
2 S1 p.
 article
201 The risk of subsequent skin cancer in patients with atypical fibroxanthoma or pleomorphic dermal sarcoma compared to the general population: a retrospective cohort study van der Waa, J.
2 S1 p.
 article
202 The RoMEO study: a real-world, observational, prospective investigation of dabrafenib and trametinib combination treatment in patients with BRAF V600 unresectable or metastatic cutaneous melanoma Mortier, L.
2 S1 p.
 article
203 The treatment of elderly patients with locally advanced or metastatic cutaneous squamous cell carcinoma using Cemiplimab monotherapy or Cemiplimab associated with palliative radiotherapy: A single centre experience from the United Kingdom del Carpio Barreda, A.
2 S1 p.
 article
204 The use of High Frequency Ultrasound in Cutaneous Oncology Surgery Tovo, L.F.
2 S1 p.
 article
205 Time interval between Sentinel Lymph Node Biopsy and Excision of Primary Melanoma does not impact long term outcomes in a large UK cohort Kounidas, G.
2 S1 p.
 article
206 Title: Survival Analysis of Patients with Non-Cutaneous Metastatic Melanoma Treated in a Reference Center in Northeast Mexico Guel, T.
2 S1 p.
 article
207 Topical Rhenium-188 ionizing radiation therapy exerts high efficacy in curing non-melanoma skin cancer- Final study results Tietze, J.K.
2 S1 p.
 article
208 Total skin micrografts with punch for repair of surgical defects in acral skin Vargas, P.
2 S1 p.
 article
209 Tumor microenvironment (TME) features and serum cytokines in patients with metastatic uveal and cutaneous melanoma treated with tebentafusp Hamid, O.
2 S1 p.
 article
210 Ultrasonography for the diagnosis and follow-up of extramammary Paget's disease (EMPD). A case-report Sánchez-Puigdollers, A.
2 S1 p.
 article
211 Unlocking Potential in Clinical Practice: A Comprehensive Assessment of an Artificial Intelligence Based Clinical Decision Support System for Cutaneous Melanoma Detection Papachristou, P.
2 S1 p.
 article
212 Unraveling the Impact of Microbiome on Immunotherapy Efficacy in Melanoma Bagué Companys, J.
2 S1 p.
 article
213 Unresectable endocrine mucin-producing sweat gland carcinoma revealing an actionable somatic CHEK2 gene mutation Tzoumpa, S.
2 S1 p.
 article
214 Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France Dalle, S.
2 S1 p.
 article
215 Updates on CTCL diagnostic and therapeutic trends amidst the COVID-19 pandemic: insights from a referral center Roccuzzo, G.
2 S1 p.
 article
216 Usability of a smartphone app for skin cancer detection Kips, J.
2 S1 p.
 article
217 Use of 3-dimensional total body photography and digital dermoscopy with artificial intelligence algorithms for early melanoma detection in high-risk patients Serra-García, L.
2 S1 p.
 article
218 Use of Immune Checkpoint Inhibitor (ICI) Therapy for Cutaneous Melanoma from 2014 to 2021 in Norway: Insights from Real-World Data Reis Costa, D.
2 S1 p.
 article
219 Using a clinicopathologic and gene expression model to predict prognosis in stage I-II primary cutaneous melanoma: a multicenter Danish cohort study Weitemeyer, M.B.-M.
2 S1 p.
 article
220 Using the free flap to repair the postoperative defect of the head and neck squamous cell carcinomaUsing the free flap to repair the postoperative defect of the head and neck squamous cell carcinoma Sun, Y.
2 S1 p.
 article
221 Validation of the Melanoma Institute Australia Prediction Tool for Sentinel Node Metastasis Risk Amongst Patients with Cutaneous Head and Neck Melanoma Li, A.T.
2 S1 p.
 article
222 What is the quality-of-life impact of basal cell carcinoma in older patients? A multicentric cross-sectional study Van Coile, L.
2 S1 p.
 article
223 Whole transcriptome sequencing: Optimizing molecular classification and management of rare skin cancers Louveau, B.
2 S1 p.
 article
                             223 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands